Our top pick for
Building a portfolio
AMTD International Inc is a capital markets business based in the US. AMTD International shares (HKIB) are listed on the NYSE and all prices are listed in US Dollars. AMTD International employs 40 staff and has a market cap (total outstanding shares value) of 0.00.
|52-week range||$4.51 - $8.80|
|50-day moving average||$6.33|
|200-day moving average||$6.61|
|Wall St. target price||$10.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.80|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing AMTD International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AMTD International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AMTD International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, AMTD International shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||9.44%|
|Return on equity TTM||10.67%|
|Market capitalisation||$2.5 billion|
TTM: trailing 12 months
There are currently 10,688 AMTD International shares held short by investors – that's known as AMTD International's "short interest". This figure is 13.3% down from 12,328 last month.
There are a few different ways that this level of interest in shorting AMTD International shares can be evaluated.
AMTD International's "short interest ratio" (SIR) is the quantity of AMTD International shares currently shorted divided by the average quantity of AMTD International shares traded daily (recently around 34477.419354839). AMTD International's SIR currently stands at 0.31. In other words for every 100,000 AMTD International shares traded daily on the market, roughly 310 shares are currently held short.
However AMTD International's short interest can also be evaluated against the total number of AMTD International shares, or, against the total number of tradable AMTD International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AMTD International's short interest could be expressed as 0% of the outstanding shares (for every 100,000 AMTD International shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable AMTD International shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AMTD International.
Find out more about how you can short AMTD International stock.
We're not expecting AMTD International to pay a dividend over the next 12 months.
AMTD International Inc. , an investment holding company, engages in investment banking activities in Hong Kong, Mainland China, the United States, and internationally. The company operates through three segments: Investment Banking, Asset Management, and Strategic Investment. It offers a range of investment banking services, including equity underwriting, debt underwriting, securities brokerage, institutional sales and distribution, and research, as well as advisory services on credit rating, financing, and mergers and acquisitions transactions. The company also provides professional investment management and advisory services primarily to corporate and other institutional clients. In addition, it makes long-term strategic investments focusing on Asia's financial and new economy sectors. The company was formerly known as AMTD Inc.
Everything we know about the Talaris Therapeutics IPO, plus information on how to buy in.
Everything we know about the Sagimet Biosciences IPO, plus information on how to buy in.
Everything we know about the Zenvia IPO, plus information on how to buy in.
Everything we know about the Grove IPO, plus information on how to buy in.
Everything we know about the Pasithea Therapeutics IPO, plus information on how to buy in.
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.